Zacks Investment Research Lowers MedEquities Realty Trust (MRT) to Strong Sell

Share on StockTwits

Zacks Investment Research cut shares of MedEquities Realty Trust (NYSE:MRT) from a hold rating to a strong sell rating in a research report released on Saturday morning.

According to Zacks, “MedEquities Realty Trust, Inc. owns, develops, operates, leases and disposes healthcare properties and portfolios. It operates primarily in Texas, California, Nevada and South Carolina. MedEquities Realty Trust, Inc. is based in Nashville, Tennessee. “

MRT has been the subject of several other research reports. ValuEngine upgraded shares of MedEquities Realty Trust from a sell rating to a hold rating in a research report on Tuesday, July 10th. Citigroup cut shares of MedEquities Realty Trust from a neutral rating to a sell rating and lowered their price target for the stock from $10.00 to $9.00 in a research report on Friday. KeyCorp cut shares of MedEquities Realty Trust from an overweight rating to a hold rating and set a $12.00 price target for the company. in a research report on Wednesday, August 8th. B. Riley set a $12.00 price target on shares of MedEquities Realty Trust and gave the stock a buy rating in a research report on Thursday, August 9th. Finally, Royal Bank of Canada reiterated a sector perform rating and set a $11.00 price target (down previously from $12.00) on shares of MedEquities Realty Trust in a research report on Wednesday, May 23rd. Three research analysts have rated the stock with a sell rating, three have issued a hold rating and four have given a buy rating to the company. MedEquities Realty Trust currently has a consensus rating of Hold and an average price target of $12.00.

MRT opened at $9.66 on Friday. The stock has a market capitalization of $328.50 million, a price-to-earnings ratio of 8.59 and a beta of -0.16. MedEquities Realty Trust has a 1-year low of $9.46 and a 1-year high of $12.05.

MedEquities Realty Trust (NYSE:MRT) last posted its quarterly earnings data on Wednesday, August 8th. The financial services provider reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.30 by ($0.20). The company had revenue of $17.56 million during the quarter, compared to analyst estimates of $17.03 million. MedEquities Realty Trust had a net margin of 30.84% and a return on equity of 5.73%. equities research analysts forecast that MedEquities Realty Trust will post 1.11 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 29th. Investors of record on Wednesday, August 15th were issued a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 8.70%. The ex-dividend date was Tuesday, August 14th. MedEquities Realty Trust’s dividend payout ratio is currently 73.68%.

A number of hedge funds and other institutional investors have recently modified their holdings of MRT. Los Angeles Capital Management & Equity Research Inc. acquired a new position in MedEquities Realty Trust during the second quarter valued at approximately $131,000. People s United Financial Inc. acquired a new position in MedEquities Realty Trust during the second quarter valued at approximately $158,000. Bank of Montreal Can acquired a new position in MedEquities Realty Trust during the second quarter valued at approximately $160,000. Barclays PLC grew its holdings in MedEquities Realty Trust by 252.2% during the first quarter. Barclays PLC now owns 16,016 shares of the financial services provider’s stock valued at $168,000 after purchasing an additional 11,469 shares during the period. Finally, California Public Employees Retirement System acquired a new position in MedEquities Realty Trust during the second quarter valued at approximately $171,000. Hedge funds and other institutional investors own 90.80% of the company’s stock.

About MedEquities Realty Trust

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Read More: Calculate Your Return on Investment (ROI)

Get a free copy of the Zacks research report on MedEquities Realty Trust (MRT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Zacks Investment Research Lowers MedEquities Realty Trust  to Strong Sell
Zacks Investment Research Lowers MedEquities Realty Trust to Strong Sell
Churchill Downs  Lifted to “Sell” at BidaskClub
Churchill Downs Lifted to “Sell” at BidaskClub
Apogee Enterprises  Downgraded to Sell at BidaskClub
Apogee Enterprises Downgraded to Sell at BidaskClub
Brokerages Expect Platform Specialty Products Corp  Will Post Quarterly Sales of $502.00 Million
Brokerages Expect Platform Specialty Products Corp Will Post Quarterly Sales of $502.00 Million
Brokerages Expect TransUnion  to Post $0.63 EPS
Brokerages Expect TransUnion to Post $0.63 EPS
Penske Automotive Group, Inc.  Position Raised by Bank of New York Mellon Corp
Penske Automotive Group, Inc. Position Raised by Bank of New York Mellon Corp


Leave a Reply

© 2006-2018 Ticker Report. Google+.